October 2, 2012
Dr Kassa Darge has been invited to serve on the board of the International Contrast Ultrasound Society (ICUS) as the representative of the SPR. The two organizations are linking web pages, and there will be collaboration between ICUS and the SPR contrast ultrasound task force.
August 24, 2012
After a review of GE Healthcare's March 2012 Supplemental New Drug Application for proposed label changes, the U.S. Food and Drug Administration, or FDA, made revisions to the Prescribing Information for Optison, including removal of the statement, "In patients with pulmonary hypertension or unstable cardiopulmonary conditions, monitor vital sign measurements, electrocardiography and cutaneous oxygen saturation during and for at least 30 minutes after Optison administration", from within the previous BOXED WARNING. Similar language was also removed from the WARNING section of the label.
July 3, 2012
There will be a pediatric contrast ultrasound sunrise session at the SPR meeting in San Antonio on Friday morning, May 17, 2013. Many of our national leaders in this exciting emerging modality will be speaking.
March 28, 2012
New Images/Cases added above - IRR-VUR in meggaureter - Kassa Darge, MD, PhD & Liver Laceration & Kidney Perfursion defect Not Seen On Grey-Scale Ultrasound - Doris Franke, MD
March 23, 2012
The Contrast Ultrasound Task Force will be meeting in San Francisco at the SPR Annual Meeting. During the meteting, there will be discussions on relationships with manufacturers, off-label use, and investigator sponsored trials. The Task Force is hoping to have a session on Contrast Ultrasound at the 2013 SPR Annual Meeting in San Antonio, Texas.
September 22-23, 2011
International Contrast Ultrasound Society Bubble Conference Update. The ICUS meeting took place September 22-23 in Chicago. It was an interesting mix of bench scientists, cardiologists, and radiologists. The first part was a summary of current efforts to promote contrast ultrasound approval by ultrasound societies around the world.